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Abstract. In this paper, we study the trade-offs of different inference
approaches for Bayesian matrix factorisation methods, which are com-
monly used for predicting missing values, and for finding patterns in the
data. In particular, we consider Bayesian nonnegative variants of matrix
factorisation and tri-factorisation, and compare non-probabilistic infer-
ence, Gibbs sampling, variational Bayesian inference, and a maximum-
a-posteriori approach. The variational approach is new for the Bayesian
nonnegative models. We compare their convergence, and robustness to
noise and sparsity of the data, on both synthetic and real-world datasets.
Furthermore, we extend the models with the Bayesian automatic rele-
vance determination prior, allowing the models to perform automatic
model selection, and demonstrate its efficiency.
1 Introduction
Matrix factorisation methods have been used extensively in recent years to de-
compose matrices into latent factors, helping us reveal hidden structure and pre-
dict missing values. In particular we decompose a given matrix into two smaller
matrices so that their product approximates the original one (see Figure 1). Non-
negative matrix factorisation models [9] have been particularly popular, as the
nonnegativity constraint makes the resulting matrices easier to interpret, and
is often inherent to the problem—such as in image processing or bioinformat-
ics [9,20]. A related problem is that of matrix tri-factorisation, first introduced
by Ding et al. (2006) [6], where the observed dataset is decomposed into three
smaller matrices, which again are constrained to be non-negative.
Both matrix factorisation and tri-factorisation methods have found many
applications in recent years, such as for collaborative filtering [13,5], sentiment
classification [11], predicting drug-target interaction [8] and gene functions [12],
and image analysis [23]. Methods can be categorised as either non-probabilistic
or Bayesian. For the former, finding the factorisation (inference) is commonly
done using multiplicative updates, whereas for the latter we use approximate
Bayesian inference methods. Non-probabilistic or maximum a posteriori (MAP)
solutions give a single point estimate, which can lead to overfitting more easily
and neglects uncertainty. Bayesian approaches address this issue, by instead find-
ing a full distribution over the matrices, where we define prior distributions over
the matrices and then compute their posterior after observing the actual data.
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Fig. 1: Overview of matrix factorisation and matrix tri-factorisation methods,
with missing values (?-entries).
This can greatly reduce overfitting. A key question that arises is: what exactly
are the trade-offs between different matrix factorisation inference approaches?
In particular, which perform better in terms of speed of convergence, predictive
performance, and robustness to noise and sparsity?
In this paper we answer these questions by performing a thorough empir-
ical study to explore these trade-offs between non-probabilistic and Bayesian
inference approaches, which to our knowledge had not been done before. We
consider the popular non-probabilistic matrix factorisation model from Lee and
Seung (2000) [10], and a Bayesian nonnegative matrix factorisation and tri-
factorisation model from Schmidt et al. (2009) [15] and Brouwer and Lio´ (2017)
[4], respectively. These models use exponential priors to enforce nonnegativity,
giving Gibbs sampling algorithms for inference. The former paper also intro-
duced a MAP algorithm, called iterated conditional modes (ICM). Both of these
approaches rely on a sampling procedure to eventually converge to draws of the
desired distribution—in this case the posterior of the matrices. This means that
we need to inspect the values of the draws to determine when our method has
converged (burn-in), and then take additional draws to estimate the posteriors.
We introduce a fourth inference technique for the Bayesian nonnegative mod-
els, based on variational Bayesian inference (VB), where instead of relying on
random draws we obtain deterministic convergence to a solution. We do this by
introducing a new distribution that is easier to compute, and optimise it to be
as similar to the true posterior as possible. Some papers (for instance [14]) assert
that variational inference gives faster but less accurate inference than sampling
methods like Gibbs. One study investigating this for latent dirichlet allocation
can be found in [1], but ours is the first paper giving a thorough empirical study
of the trade-offs for matrix factorisation. We furthermore extend the Bayesian
models with automatic relevance determination (ARD), to eliminate the need
for model selection.
We perform extensive experiments on both artificial and real-world data to
explore the trade-offs between speed of inference, and robustness to sparsity and
noise for predicting missing values. We show that Gibbs sampling is the most
robust, while VB and ICM give significant run-time speedups but sacrifice some
robustness, and that non-probabilistic inference tends to be fast but not robust.
Finally, we show that ARD is an effective way of performing automatic model
selection, and increases the robustness of matrix factorisation models if they are
given the wrong dimensionality.
Although we study a specific Bayesian nonnegative matrix factorisation and
tri-factorisation model, we believe that many of our findings and insights apply
to the broad range of other matrix factorisation and tri-factorisation methods,
as well as tensor and Tucker decomposition methods—their three-dimensional
extensions.
2 Models
2.1 Nonnegative Matrix Factorisation
We follow the notation used by Schmidt et al. (2009) [15] for nonnegative matrix
factorisation (NMF), which can be formulated as decomposing a matrix R ∈
RI×J into two latent (unobserved) matrices U ∈ RI×K+ and V ∈ RJ×K+ , whose
values are constrained to be positive. In other words, solving R = UV T +
E, where noise is captured by matrix E ∈ RI×J . The dataset R need not be
complete—the indices of observed entries can be represented by the set Ω =
{(i, j) | Rij is observed}. These entries can then be predicted by UV T .
We take a probabilistic approach to this problem. We express a likelihood
function for the observed data, and treat the latent matrices as random variables.
As the likelihood we assume each value of R comes from the product of U and
V , with some Gaussian noise added,
Rij ∼ N (Rij |U i · V j , τ−1)
where U i,V j denote the ith and jth rows of U and V , and N (x|µ, τ) =
τ
1
2 (2pi)−
1
2 exp
{− τ2 (x− µ)2} is the density of the Gaussian distribution with
precision τ . The set of parameters for our model is denoted θ = {U ,V , τ}. In
the Bayesian approach to inference, we want to find the distributions over pa-
rameters θ after observing the data D = {Rij}i,j∈Ω . We can use Bayes’ theorem,
p(θ|D) ∝ p(D|θ)p(θ).
We need priors over the parameters, allowing us to express beliefs for their
values—such as constraining U ,V to be nonnegative. We can normally not
compute the posterior p(θ|D) exactly, but some choices of priors allow us to
obtain a good approximation. Schmidt et al. choose an exponential prior over
U and V , so that each element in U and V is assumed to be independently
exponentially distributed with rate parameters λUik, λ
V
jk > 0.
Uik ∼ E(Uik|λUik) Vjk ∼ E(Vjk|λVjk)
where E(x|λ) = λ exp {−λx}u(x) is the density of the exponential distribution,
and u(x) is the unit step function. For the precision τ we use a Gamma distri-
bution with shape ατ > 0 and rate βτ > 0,
p(τ) ∼ G(τ |ατ , βτ ) = βτ
ατ
Γ (ατ )
xατ−1e−βτx
where Γ (x) =
∫∞
0
xt−1e−xdt is the gamma function.
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Fig. 2: Graphical model representation of Bayesian nonnegative matrix factori-
sation (left) and tri-factorisation (right), with ARD.
2.2 Nonnegative Matrix Tri-Factorisation
The problem of nonnegative matrix tri-factorisation (NMTF) can be formulated
similarly to that of nonnegative matrix factorisation, and was introduced by
Brouwer and Lio´ (2017) [4]. We now decomposeR into three matrices F ∈ RI×K+ ,
S ∈ RK×L+ , G ∈ RJ×L+ , so that R = FSGT + E. This decomposition has the
advantage of extracting row and column factor values separately (through F
and G), allowing us to identify both row and column clusters. We again use a
Gaussian likelihood and Exponential priors for the latent matrices.
Rij ∼ N (Rij |F i · S ·Gj , τ−1) τ ∼ G(τ |ατ , βτ )
Fik ∼ E(Fik|λFik) Skl ∼ E(Skl|λSkl) Gjl ∼ E(Gjl|λGjl)
2.3 Automatic Relevance Determination
Automatic relevance determination (ARD) is a Bayesian prior which helps per-
form automatic model selection. It works by replacing the individual λ parame-
ters in the factor matrix priors by one that is shared by all entries in the same
column (in other words, shared for each factor). We then place a further Gamma
prior over all these λk parameters. For the NMF model, the priors become
Uik ∼ E(Uik|λk) Vjk ∼ E(Vjk|λk) λk ∼ G(λk|α0, β0).
Since this parameter is shared by all entries in the same column, the entire factor
k is either activated (if λtk has a low value) or “turned off” (if λ
t
k has a high
value), pushing factors that are active for only a few entities further to zero.
This prior has been used for both real-valued [19,18] and nonnegative matrix
factorisation [17]. Instead of having to choose the correct K, we give an upper
bound and the model will automatically determine the number of factors to use.
A similar approach can be found in [7], which incorporates the elimination of
unused factors into their expectation-maximisation inference algorithm. ARD is
implemented on a model level, and therefore works with all inference approaches.
For NMTF we use two ARD’s, one for F (λFk ) and another for G (λ
G
l ),
Fik ∼ E(Fik|λFk ) λFk ∼ G(λFk |α0, β0) Gjl ∼ E(Gjl|λGl ) λGl ∼ G(λGl |α0, β0).
The graphical models for Bayesian NMF and NMTF are given in Figure 2.
3 Inference
In this section we give details for four different types of inference for nonneg-
ative matrix factorisation (NMF) and tri-factorisation (NMTF) models. Non-
probabilistic inference gives a point estimate solution. Gibbs sampling and vari-
ational Bayesian inference both give a full posterior estimate, whereas iterated
conditional modes gives a maximum a posteriori (MAP) point estimate.
3.1 Non-Probabilistic Inference
A non-probabilistic (NP) approach for NMF can be found in Lee and Seung
(2000) [10]. Their algorithm relies on multiplicative updates, where at each it-
eration the values in the U and V matrices are updated using the following
values:
Uik = Uik
∑
j∈Ωi RijVjk/(U iV j)∑
j∈Ωi Vjk
Vjk = Vjk
∑
i∈Ωj RijUik/(U iV j)∑
i∈Ωj Uik
where Ωi = {j | (i, j) ∈ Ω} and Ωj = {i | (i, j) ∈ Ω}. These updates can be
shown to minimise the I-divergence (generalised KL-divergence),
D(R||UV T ) =
∑
(i,j)∈Ω
(
Rij log
Rij
(UV T )ij
−Rij + (UV T )ij
)
.
Yoo and Choi (2009) [22] extended this approach to NMTF, giving the following
multiplicative updates, with S·l denoting the lth column of S:
Fik = Fik
∑
j∈Ωi Rij(SkGj)/(F iSGj)∑
j∈Ωi(SkGj)
Gjl = Gjl
∑
i∈Ωj Rij(F iS·l)/(F iSGj)∑
i∈Ωj (F iS·l)
Skl = Skl
∑
(i,j)∈Ω RijFikGjl/(F iSGj)∑
(i,j)∈Ω FikGjl
.
3.2 Gibbs Sampling
Schmidt et al. [15] introduced a Gibbs sampling algorithm for approximating
the posterior distribution—a similar NMF model that uses Gibbs sampling can
be found in [24,25]. Gibbs sampling works by sampling new values for each
parameter θi from its marginal distribution given the current values of the other
parameters θ−i, and the observed data D. If we sample new values in turn for
each parameter θi from p(θi|θ−i, D), we will eventually converge to draws from
the posterior, which can be used to approximate the posterior p(θ|D). We have
to discard the first n draws because it takes a while to converge (burn-in), and
since consecutive draws are correlated we only use every ith value (thinning).
For NMF this means that we need to be able to draw from distributions
p(τ |U ,V ,λ, D) p(Uik|τ,U−ik,V ,λ, D)
p(λk|τ,U ,V , D) p(Vjk|τ,U ,V −jk,λ, D).
where U−ik denotes all elements in U except Uik, and similarly for V −jk. λ is
a vector including all λk values. Using Bayes theorem we obtain the following
posterior distributions:
p(τ |U ,V ,λ, D) = G(τ |α∗τ , β∗τ ) p(Uik|τ,U−ik,V ,λ, D) = T N (Uik|µUik, τUik)
p(λk|τ,U ,V , D) = G(λk|α∗k, β∗k) p(Vjk|τ,U ,V −jk,λ, D) = T N (Vjk|µVjk, τVjk)
where
T N (x|µ, τ) =

√
τ
2pi exp
{− τ2 (x− µ)2}
1− Φ(−µ√τ) if x ≥ 0
0 if x < 0
is a truncated normal: a normal distribution with zero density below x = 0 and
renormalised to integrate to one. Φ(·) is the cumulative distribution function of
N (0, 1).
For NMTF we can derive a Gibbs sampling algorithm similarly, as done by
Brouwer and Lio´ [4]. The posteriors, together with the parameter values for both
Gibbs samplers, are given in the supplementary materials.
3.3 Iterated Conditional Modes
The iterated conditional models (ICM) algorithm for inference in the NMF model
was given in Schmidt et al. [15]. It works very similarly to the Gibbs sampler,
but instead of randomly drawing a value from the conditional posteriors, we
take the mode at each iteration. This gives a maximum a posteriori (MAP)
point estimate θMAP = maxθ p(θ|D), rather than a full posterior distribution.
We furthermore still need to use thinning and burn-in. For random variables
X ∼ G(a, b), Y ∼ T N (µ, τ), the modes are a−1b and max (0, µ), respectively.
In practice ICM often converges to solutions where multiple columns in the
matrices are all zeros, leading to poor approximations. We have addressed this
issue by resetting zeros to a small positive value like 0.1 at each iteration.
3.4 Variational Bayesian Inference
Variational Bayesian inference (VB) has been used for other matrix factorisation
models before [8], but not for the nonnegative model in this paper. We therefore
now introduce a new VB algorithm for our model. Like Gibbs sampling, VB
is a way to approximate the true posterior p(θ|D). The idea behind VB is to
introduce an approximation q(θ) to the true posterior that is easier to compute,
and to make our variational distribution q(θ) as similar to p(θ|D) as possible (as
measured by the KL-divergence). We assume the variational distribution q(θ)
factorises completely, so all variables are independent in the posterior,
q(θ) =
∏
θi∈θ
q(θi).
This is called the mean-field assumption. We use the same forms of q(θi) as we
used in Gibbs sampling,
q(τ) = G(τ |α∗τ , β∗τ ) q(λk) = G(λk|α∗k, β∗k)
q(Uik) = T N (Uik|µUik, τUik) q(Vjk) = T N (Vjk|µVjk, τVjk).
It can be shown [3] that the optimal distribution for the ith parameter, q∗(θi),
can be expressed as follows (for some constant C), allowing us to find the optimal
updates for the variational parameters.
log q∗(θi) = Eq(θ−i) [log p(θ, D)] + C.
We now take the expectation with respect to the distribution q(θ−i) over the
parameters but excluding the ith one. This gives rise to an iterative algorithm:
for each parameter θi we update its distribution to that of its optimal variational
distribution, and then update the expectation and variance with respect to q.
We therefore need updates for the variational parameters, and to be able to
compute the expectations and variances of the random variables. This algorithm
is guaranteed to maximise the Evidence Lower Bound (ELBO)
L = Eq [log p(θ, D)− log q(θ)] ,
which is equivalent to minimising the KL-divergence.
We use f˜(X) as a shorthand for Eq [f(X)], where X is a random variable and
f is a function over X. For random variables X ∼ G(a, b) and Y ∼ T N (µ, τ)
the variance and expectation are
X˜ =
a
b
Y˜ = µ+
1√
τ
λ
(−µ√τ) Var [Y ] = 1
τ
[
1− δ (−µ√τ)] ,
where ψ(x) = ddx logΓ (x) is the digamma function, λ(x) = φ(x)/[1−Φ(x)], and
δ(x) = λ(x)[λ(x)−x]. φ(x) = 1√
2pi
exp{− 12x2} is the density function of N (0, 1).
The updates for NMF are given in the supplementary materials. Our VB
algorithm for NMTF follows the same steps as before, but now has an added
complexity due to the term Eq
[
(Rij − F i · S ·Gj)2
]
. Before, all covariance terms
for k′ 6= k were zero due to the factorisation in q, but we now obtain some
additional non-zero covariance terms:
Eq
[
(Rij − F i · S ·Gj)2
]
=
(
Rij −
K∑
k=1
L∑
l=1
F˜ikS˜klG˜jl
)2
+
K∑
k=1
L∑
l=1
Varq [FikSklGjl] (1)
+
K∑
k=1
L∑
l=1
∑
k′ 6=k
Cov [FikSklGjl, Fik′Sk′lGjl] (2)
+
K∑
k=1
L∑
l=1
∑
l′ 6=l
Cov [FikSklGjl, FikSkl′Gjl′ ] . (3)
The above variance and covariance terms are equal to the following, respectively,
leading to the variational updates given in the supplementary materials.
F˜ 2ikS˜
2
klG˜
2
jl − F˜ik
2
S˜kl
2
G˜jl
2
, Varq [Fik] S˜klG˜jlS˜kl′G˜jl′ , F˜ikS˜klVarq [Gjl] F˜ik′ S˜k′l.
3.5 Complexity
Each of the four approaches have the same time complexities, but vary in how
efficiently the updates can be computed, and how quickly they converge. The
time complexity per iteration for NMF is O(IJK2), and O(IJ(K2L + KL2))
for NMTF. However, the updates in each column of U ,V ,F ,G are independent
of each other and can therefore be updated in parallel. For Gibbs and ICM
this means we can draw these values in parallel, but for VB and NP we can
jointly update the columns using a single matrix operation. Modern computer
architectures can exploit this using vector processors, leading to a great speedup.
Furthermore, after the VB algorithm converges we have our approximation
to the posterior distributions immediately, whereas with Gibbs and ICM we
need to obtain further draws after convergence and use a thinning rate to obtain
an accurate MAP (ICM) or posterior (Gibbs) estimate. This deterministic be-
haviour of VB and NP makes them easier to use. Although additional variables
need to be stored to represent the posteriors, this does not result in a worse
space complexity, as the Gibbs sampler needs to store draws over time.
3.6 Initialisation
Initialising the parameters of the models can vastly influence the quality of
convergence. This can be done by using the hyperparameters λUik, λ
V
jk, λ
F
ik, λ
S
kl,
λGjl, α, β, α0, β0, α
F
0 , β
F
0 , α
G
0 , β
G
0 to set the initial values to the mean of the
priors of the model, or using random draws. We found that random draws tend
to give faster and better convergence than the expectation, as it provides a better
initial guess of the right patterns in the matrices. For matrix tri-factorisation we
Table 1: Overview of the four drug sensitivity datasets, giving the number of cell
lines (rows), drugs (columns), and the fraction of entries that are observed.
Dataset Cell lines Drugs Fraction observed
GDSC IC50 707 139 0.806
CTRP EC50 887 545 0.801
CCLE IC50 504 24 0.965
CCLE EC50 504 24 0.630
can initialise F by running the K-means clustering algorithm on the rows as
datapoints, and similarly G for the columns, as suggested by Ding et al. (2006)
[6]. For the VB and NP algorithms we then set the µ parameters to the cluster
indicators, and for Gibbs and ICM we add 0.2 for smoothing. We found that
this improved the convergence as well, with S initialised using random draws.
3.7 Software
Implementations of all methods, the datasets, and experiments described in the
next section, are available at https://github.com/ThomasBrouwer/BNMTF_ARD.
4 Experiments
To demonstrate the trade-offs between the four inference methods presented, we
conducted experiments on synthetic data and four real-world drug sensitivity
datasets. We compare the convergence speed, robustness to noise, and robustness
to sparsity.
4.1 Datasets
For the synthetic datasets we generated the latent matrices using unit mean
exponential distributions, and adding zero mean unit variance Gaussian noise to
the resulting product. For the matrix factorisation model we used I = 100, J =
80,K = 10, and for the matrix tri-factorisation I = 100, J = 80,K = 5, L = 5.
We considered four drug sensitivity datasets, each detailing the effectiveness
(IC50 or EC50 values) of a range of drugs on different cell lines for cancer and
tissue types, where some of the entries are missing. We consider the Genomics
of Drug Sensitivity in Cancer (GDSC v5.0 [21], IC50), Cancer Therapeutics
Response Portal (CTRP v2 [16], EC50), and Cancer Cell Line Encyclopedia
(CCLE [2], IC50 and EC50). The four datasets are summarised in Table 1, giving
the number of cell lines, drugs, and the fraction of entries that are observed.
In some experiments we focused on a selection of the datasets, but results
for all can be found in the supplementary materials, together with preprocessing
details. For all models we used weak priors (λ = 0.1, ατ = βτ = α0 = β0 = 1).
(a) Synthetic (b) GDSC (c) CTRP (d) CCLE IC50 (e) CCLE EC50
Fig. 3: Convergence of algorithms on the synthetic and drug sensitivity datasets,
measuring the training data fit (mean square error) across iterations, for each of
the inference approaches for NMF (top row) and NMTF (bottom row).
4.2 Convergence Speed
We firstly measured the convergence speeds of the different inference methods on
the datasets, using the versions of NMF and NMTF without ARD. Convergence
plots on all datasets are given in Figure 3, plotting the mean squared error on the
training data against the number of iterations, for NMF (top row) and NMTF
(bottom row). For the synthetic data we used the correct number of factors, and
for the drug sensitivity datasets we used K = 20 for NMF and K = L = 10 for
NMTF. We ran each method 20 times, taking the average training errors.
Although the results are empirical, they show that the inference approaches
have different convergence speeds and depths (final training error reached). On
the synthetic data VB is the fastest, followed by ICM and Gibbs, and finally NP.
All methods reach the optimal MSE of 1 (which is the level of noise added). On
the real-world drug sensitivity datasets, all methods reach their lowest depth at
roughly the same number of iterations. However, ICM and NP generally converge
much deeper than VB and Gibbs. Although this initially seems good, this is a sign
of overfitting to the training data, and can lead to poor predictions for unseen
data. We will see this later in the noise and sparsity experiments (Sections 4.4
and 4.5), where VB and Gibbs are more robust than ICM and NP.
In the supplementary materials we also give the convergence speed against
time taken, which shows that the NP approach takes the least amount of time
per iteration, followed by ICM, VB, and then Gibbs. In summary, ICM and NP
give the fastest convergence, followed by VB, and then Gibbs.
4.3 Cross-Validation
Next we measured the cross-validation performances of the methods on the four
drug sensitivity datasets. For each method we performed 10-fold nested cross-
validation (nested to pick the dimensionality K—for simplicity we used L = K
Fig. 4: 10-fold cross-validation results (mean squared error) for drug sensitivity
predictions on each of the four datasets. Each boxplot gives the median (red
line), standard deviation (blue box), and upper quartiles (black lines).
for the NMTF models), giving the average performance in Figure 4. For the
ARD models we did not need to pick the dimensionality, instead using K = 20
for NMF, and K = 10, L = 10 for NMTF.
We can see that most models perform very similarly, with little to no differ-
ence between the matrix factorisation and tri-factorisation versions. Using the
ARD models often works equally well as without ARD, but with the added ben-
efit of not having to run nested cross-validation to choose the dimensionality,
reducing the running time from hours to minutes. However, sometimes ARD
fails to prevent overfitting, such as for VB NMF on CTRP EC50, and Gibbs
NMF on CCLE EC50). This is unsurprising as the ARD models are given di-
mensionalities that are way too high. We will see in Section 4.6 that the ARD is
actually very efficient at turning off unnecessary factors and reducing overfitting.
We can also see that the VB and Gibbs models often do a bit better than the
NP and ICM versions. This is especially obvious on the CCLE IC50 dataset, and
also on GDSC IC50. On the CCLE EC50 dataset the NP NMF model completely
overfits on one of the folds, leading to extremely high predictive errors.
4.4 Noise Test
We conducted a noise test on the synthetic data to measure the robustness of
the methods. We add different levels of Gaussian noise to the data, with the
noise-to-signal ratio being given by the ratio of the standard deviation of the
Gaussian noise we add, to the standard deviation of the generated data. For
each noise level we split the datapoints randomly into ten folds, and measure
the predictive performance of the models on one held-out set. The results are
given in Figures 5a (NMF) and 5b (NMTF), where we can see that the non-
probabilistic approach starts overfitting heavily at low levels of noise, whereas
the Bayesian approaches achieve the best possible predictive powers even at high
levels of noise. In the supplementary materials we also show that adding ARD
did not make a difference for the robustness of the Bayesian models.
4.5 Sparsity Test
We furthermore measured the robustness of each inference technique to sparsity
of the data. For different fractions of missing values we randomly split the data
ten times into train and test sets using those proportions, and measured the
average predictive error. We conducted this experiment on the synthetic data,
using the true dimensionality K (and L) for each model. We also performed it
on the GDSC and CTRP datasets, using the most common dimensionalities in
the cross-validation from Section 4.3 (given in supplementary materials).
The results are given in Figures 6a (NMF) and 6d (NMTF) for the synthetic
data, 6b and 6e for GDSC, and 6c and 6f for CTRP. We can see that the non-
probabilistic models start overfitting even on very low sparsity levels (with the
exception of 6d)—in Figure 6a we cannot even see the line. The ICM models
are also less robust when the sparsity is high. In contrast, the Gibbs sampling
model achieves very good predictive performance even under extreme sparsity.
The VB models are similar, but for sparser data it can sometimes not find the
best solution, as can be seen in Figure 6d. We conducted this experiment for the
models with ARD as well (results given in supplementary materials), where we
show that ARD makes no difference to the robustness of Gibbs and VB (which
are already very robust), but for ICM it can sometimes improve results.
4.6 Model Selection
Finally, we conducted an experiment to see the extent of overfitting if the model
is given a high dimensionality K, and whether this is remedied through the use
of ARD. If we give a model a higher dimensionality, it can fit more to the data,
but this can lead to overfitting and a higher predictive error. ARD can remedy
this by turning off scarsely used factors, hopefully leading to less overfitting.
On the GDSC dataset, we performed 10-fold cross-validation for different
values of K (and L for NMTF, using K = L) for Gibbs, VB, and ICM. We show
these results in Figures 7a to 7f, where the results for models without ARD
are given by crosses (x) and with ARD by circles (o). We can see that in most
graphs, the models with ARD have a much flatter line as the dimensionality
increases, hence reducing overfitting. This effect is more apparent for the NMF
models than for the NTMF ones. The only exception is NMTF ICM, where the
ARD is preventing the model from fitting as much to the data, hence leading
to poor predictive results. Results for this experiment on the other three drug
(a) NMF (b) NMTF
Fig. 5: Noise test performances, measured by average predictive performance on
test set (mean square error) for different noise-to-signal ratios.
(a) Synthetic, NMF (b) GDSC, NMF (c) CTRP, NMF
(d) Synthetic, NMTF (e) GDSC, NMTF (f) CTRP, NMTF
Fig. 6: Sparsity test performances, measured by average predictive performance
on test set (mean square error) for different sparsity levels. The top row gives
the performances for NMF, and the bottom for NMTF, for the synthetic data
(left), GDSC dataset (middle), and CTRP dataset (right).
(a) NMF VB (b) NMF Gibbs (c) NMF ICM
(d) NMTF VB (e) NMTF Gibbs (f) NMTF ICM
Fig. 7: 10-fold cross-validation performances of the Bayesian models on the
GDSC dataset, where we vary the dimensionality K (using L = K for NMTF).
The top row gives the performances for NMF, the bottom row for NMTF. Per-
formances for models without ARD are given by dotted lines and crosses (x),
with ARD by circles (o).
sensitivity datasets is given in the supplementary materials, which show that
this problem only occurred for NMTF ICM on the GDSC dataset.
5 Conclusion
We have studied the trade-offs between different inference approaches for Bayesian
nonnegative matrix factorisation and tri-factorisation models. We considered
three methods, namely Gibbs sampling, iterated conditional modes, and non-
probabilistic inference, and introduced a fourth one based on variational Bayesian
inference. We furthermore extended these models with the Bayesian automatic
relevance determination prior, to perform automatic model selection. Through
experiments on both synthetic data, and real-world drug sensitivity datasets, we
explored the trade-offs in convergence, robustness to noise, and robustness to
sparsity.
A qualitative summary based on our quantitative findings can be found in
Table 2. We found that the non-probabilistic methods are not very robust to
noise and sparsity. Gibbs sampling is the most robust of the methods, especially
for sparse datasets, and gives a full Bayesian posterior estimate. However, it
converges slowly, and requires additional samples to estimate the posterior. Iter-
ated conditional modes offers a much faster convergence and run-time speed, but
sacrifices some robustness, still requires sampling, and no longer returns a full
Table 2: Qualitative comparison of inference methods.
Requires Speed of
Method Estimate sampling convergence Robustness
Non-probabilistic Point No High Low
Iterated conditional modes Point (MAP) Yes High Medium
Gibbs sampling Full posterior Yes Low High
Variational Bayes Full posterior No Medium Fairly high
posterior (giving a MAP estimate instead). Our variational Bayesian inference
gives good convergence speeds while maintaining more robustness properties.
Finally, we have shown that ARD is an effective way of reducing overfitting
when using the wrong dimensionality in matrix factorisation models. This can
eliminate the use for performing model selection, or nested cross-validation—
although it is not perfect. We also discovered that adding ARD has little impact
on performance, or on the robustness of the models to sparsity and noise (except
for iterated conditional modes, where ARD increases its robustness to sparsity).
Our experiments were conducted for a specific version of Bayesian matrix
factorisation and tri-factorisation, but we believe they offer insights into the
trade-offs between different inference techniques in other matrix factorisation
models, as well as tensor and Tucker decomposition methods.
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1 Details of inference algorithm updates
1.1 NMF Gibbs sampling parameter values
The parameter values for the NMF Gibbs sampling algorithm are given in Table 1. These
can be derived using Bayes’ theorem as follows, using the notation defined in the main paper,
p(Uik|τ,U−ik,V ,λ) ∝ p(R|τ,U ,V )× p(Uik|λk)
∝
∏
j∈Ω1i
N (Rij|U i · V j, τ−1)× E(Uik|λk)
∝ exp
−τ2 ∑
j∈Ω1i
(Rij −U iV j)2
× exp {−λkUik} × u(x)
∝ exp
−U2ik2
τ ∑
j∈Ω1i
V 2jk

+Uik
−λk + τ ∑
j∈Ω1i
(Rij −
∑
k′ 6=k
Uik′Vjk′)Vjk
× u(x)
∝ exp
{
−τ
U
ik
2
(Uik − µUik)2
}
× u(x)
∝ T N (Uik|µUik, τUik).
1.2 NMF Gibbs sampling and Variational Bayes parameter values
The parameter values for the NMF Variational Bayesian inference algorithm are given in
Table 1. These can be derived using the following optimal expression for the variational
posterior distribution (Beal and Ghahramani [2003]),
log q∗(θi) = Eq(θ−i) [log p(θ, D)] + C,
allowing us to find the optimal updates for the variational parameters. We now take the
expectation with respect to the distribution q(θ−i) over the parameters but excluding the
ith one. The derivation for Uik is shown below. We use f˜(X) as a shorthand for Eq [f(X)],
where X is a random variable and f is a function over X. In the code implementation of
these updates we make use of the identity X˜2 = X˜2 + Varq [X].
2
q∗(Uik) ∝ exp
{
Eq(θ−Uik ) [log p(D|θ) + log p(θ)]
}
∝ exp
Eq(θ−Uik )
∑
j∈Ω1i
log p(Rij|U ,V ) + log p(Uik|λk)

∝ exp
Eq(θ−Uik )
∑
j∈Ω1i
log
[√
τ
2pi
exp
{
−τ
2
(Rij −U iV j)2
}]
+ log [λk exp {−λkUik}]
× u(x)
∝ exp
Eq(θ−Uik )
∑
j∈Ω1i
−τ
2
(Rij −U iV j)2 − λkUik
× u(x)
∝ exp
Eq(θ−Uik )
−τ
2
∑
j∈Ω1i
[
U2ikV
2
jk − 2UikVjk(Rij −
∑
k′ 6=k
Uik′Vjk′)
]− Uikλ˜k
× u(x)
∝ exp
−U2ik2
τ˜ ∑
j∈Ω1i
V˜jk
2
+ Uik
−λ˜k + τ˜ ∑
j∈Ω1i
(
Rij −
∑
k′ 6=k
U˜ik′ V˜jk′
)
V˜jk
× u(x)
∝ exp
{
−τ
U
ik
2
(Uik − µUik)2
}
× u(x)
∝ T N (Uik|µUik, τUik).
1.3 NMTF Gibbs sampling parameter values
For the NMTF Gibbs sampling algorithm we need to sample from the following posteriors:
p(τ |F ,S,G,λF ,λG, D) = G(τ |α∗τ , β∗τ )
p(Fik|τ,F−ik,S,G,λF ,λG, D) = T N (Fik|µFik, τFik)
p(Skl|τ,F ,S−kl,G,λF ,λG, D) = T N (Skl|µSkl, τSkl)
p(Gjl|τ,F ,S,G−jl,λF ,λG, D) = T N (Gjl|µGjl, τGjl )
p(λFk |F ,S,G,λF−k,λG, D) = G(λFk |αF∗k , βF∗k )
p(λGl |F ,S,G,λF ,λG−l, D) = G(λGl |αG∗l , βG∗l ).
In the above, λF is a vector including all λFk values, λ
F
−k excludes λ
F
k , and similarly for λ
G.
The updates are given in Table 2.
3
1.4 NMTF Variational Bayes parameter updates
We have the following approximations to the posteriors for the NMTF Variational Bayes
algorithm:
q(τ) = G(τ |α∗τ , β∗τ )
q(Fik) = T N (Fik|µFik, τFik)
q(Skl) = T N (Skl|µSkl, τSkl)
q(Gjl) = T N (Gjl|µGjl, τGjl )
q(λFk ) = G(λFk |αF∗k , βF∗k )
q(λGl ) = G(λGl |αG∗l , βG∗l ).
The updates are given in Table 3. The expression for Eq [(Rij − F i · S ·Gj)2] can be found
in the main paper.
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Table 1: NMF variable update rules
GIBBS SAMPLING VARIATIONAL BAYES
α∗τ ατ +
|Ω|
2
ατ +
|Ω|
2
β∗τ βτ +
1
2
∑
(i,j)∈Ω
(Rij −U iV j)2 βτ + 1
2
∑
(i,j)∈Ω
Eq
[
(Rij −U iV j)2
]
τUik τ
∑
j∈Ω1i
V 2jk τ˜
∑
j∈Ω1i
V˜ 2jk
µUik
1
τUik
(
− λk+ 1
τUik
(
− λ˜k+
τ
∑
j∈Ω1i
(Rij −
∑
k′ 6=k
Uik′Vjk′)Vjk
)
τ˜
∑
j∈Ω1i
Rij −∑
k′ 6=k
U˜ik′ V˜jk′
 V˜jk)
τVjk τ
∑
i∈Ω2j
U2ik τ˜
∑
i∈Ω2j
U˜2ik
µVjk
1
τVjk
(
− λk+ 1
τVjk
(
− λ˜k+
τ
∑
i∈Ω2j
(Rij −
∑
k′ 6=k
Uik′Vjk′)Uik
)
τ˜
∑
i∈Ω2j
Rij −∑
k′ 6=k
U˜ik′ V˜jk′
 U˜ik)
α∗k α0 + I + J α0 + I + J
β∗k β0 +
I∑
i=1
Uik +
J∑
j=1
Vjk β0 +
I∑
i=1
U˜ik +
J∑
j=1
V˜jk
Eq
[
(Rij −U iV j)2
]
=
(
Rij −
K∑
k=1
U˜ik V˜jk
)2
+
K∑
k=1
(
U˜2ikV˜
2
jk − U˜ik
2
V˜jk
2
)
5
Table 2: NMTF Gibbs update rules.
GIBBS SAMPLING
α∗τ ατ +
|Ω|
2
β∗τ βτ +
1
2
∑
(i,j)∈Ω
(Rij − F i · S ·Gj)2
τFik τ
∑
j∈Ω1i
(Sk ·Gj)2
µFik
1
τFik
−λFk + τ ∑
j∈Ω1i
(Rij −
∑
k′ 6=k
L∑
l=1
Fik′Sk′lGjl) (Sk ·Gj)

τSkl τ
∑
(i,j)∈Ω
F 2ikG
2
jl
µSkl
1
τSkl
−λSkl + τ ∑
(i,j)∈Ω
(Rij −
∑
(k′,l′)6=(k,l)
Fik′Sk′l′Gjl′)FikGjl

τGjl τ
∑
i∈Ω2j
(F i · S·,l)2
µGjl
1
τGjl
−λGl + τ ∑
i∈Ω2j
(Rij −
K∑
k=1
∑
l′ 6=l
FikSkl′Gjl′) (F i · S·,l)

αF∗k α0 + I
βF∗k β0 +
I∑
i=1
Fik
αG∗l α0 + J
βG∗l β0 +
J∑
j=1
Gjl
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Table 3: NMTF VB update rules.
VARIATIONAL BAYES
α∗τ ατ +
|Ω|
2
β∗τ βτ +
1
2
∑
(i,j)∈Ω
Eq
[
(Rij − F i · S ·Gj)2
]
τFik τ˜
∑
j∈Ω1i
( L∑
l=1
S˜klG˜jl
)2
+
L∑
l=1
(
S˜2klG˜
2
jl − S˜kl
2
G˜jl
2
)
µFik
1
τFik
−λ˜Fk + τ˜ ∑
j∈Ω1i
(Rij −∑
k′ 6=k
L∑
l=1
F˜ik′ S˜k′lG˜jl)
L∑
l=1
S˜klG˜jl −
L∑
l=1
S˜klVarq [Gjl]
∑
k′ 6=k
F˜ik′ S˜k′l

τSkl τ˜
∑
(i,j)∈Ω
F˜ 2ikG˜
2
jl
µSkl
1
τSkl
−λSkl + τ˜ ∑
(i,j)∈Ω
(Rij − ∑
(k′,l′)6=(k,l)
F˜ik′ S˜k′l′G˜jl′)F˜ikG˜jl
−F˜ikVarq [Gjl]
∑
k′ 6=k
F˜ik′ S˜k′l −Varq [Fik] G˜jl
∑
l′ 6=l
S˜kl′G˜jl′

τGjl τ˜
∑
i∈Ω2j
( K∑
k=1
F˜ikS˜kl
)2
+
K∑
k=1
(
F˜ 2ikS˜
2
kl − F˜ik
2
S˜kl
2
)
µGjl
1
τGjl
−λ˜Gl + τ˜ ∑
i∈Ω2j
(Rij − K∑
k=1
∑
l′ 6=l
F˜ikS˜kl′G˜jl′)
K∑
k=1
F˜ikS˜kl −
K∑
k=1
Varq [Fik] S˜kl
∑
l′ 6=l
S˜kl′G˜jl′

αF∗k α0 + I
βF∗k β0 +
I∑
i=1
F˜ik
αG∗l α0 + J
βG∗l β0 +
J∑
j=1
G˜jl
7
2 Implementation details
All algorithms mentioned were implemented using the Python language. The numpy pack-
age was used for fast matrix operations, and for random draws of the truncated normal
distribution we used the Python package rtnorm by C. Lassner (http://miv.u-strasbg.
fr/mazet/rtnorm/), giving more efficient draws than the standard libraries and dealing with
rounding errors.
The mean and variance of the truncated normal involve operations prone to numerical er-
rors when µ takes high negative values. To deal with this we observe that when µτ  0 the
truncated normal distribution approximates an exponential one with rate |µτ |, and therefore
has mean 1/|µτ | and variance 1/|µτ |2.
All experiments were run on a MacBook Pro laptop, with 2.2 GHz Intel Core i7 processor,
16 GB 1600 MHz DDR3 memory, and an Intel Iris Pro 1536 MB Graphics card.
3 Data preprocessing
We will now describe the preprocessing steps undertaken for the drug sensitivity datasets
used in the paper. We used four different datasets:
• Genomics of Drug Sensitivity in Cancer (GDSC v5.0, Yang et al. [2013])—giving the
natural log of IC50 values for 139 drugs across 707 cell lines, with 80% observed entries.
• Cancer Therapeutics Response Portal (CTRP v2, Seashore-Ludlow et al. [2015])—
giving EC50 values for 545 drugs across 887 cell lines, with 80% observed entries.
• Cancer Cell Line Encyclopedia (CCLE, Barretina et al. [2012])—giving both IC50 and
EC50 values for 24 drugs across 504 cell lines, with 96% and 63% observed entries
respectively.
IC50 values indicate the required drug concentration needed to reduce the activity of a given
cell line (cancer type in a tissue) by half. We thus measure when an undesired effect has
been inhibited by half. With EC50 values we measure the maximal (desired) effect a drug
can have on a cell line, and then measure the concentration of the drug where we achieve
half of this value. In both cases, a lower value is better.
The values in the CCLE datasets were in the range [0,8] for IC50, and [0,10] for EC50. The
CTRP values were all nonnegative, with some very high values, so we capped them at 100.
For the GDSC dataset we undid the natural log transform by taking the exponent, making
all values nonnegative, and then also capped high values at 100. For this dataset we also
had two cell lines with only one and two observed entries, so we filtered them out.
Distributions of the values are plotted in Figure 1. A summary of the datasets can also be
found in Table 4.
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Table 4: Overview of the four drug sensitivity datasets, giving the number of cell lines
(rows), drugs (columns), observed entries, and the fraction of entries that are observed.
Dataset Cell lines Drugs Entries observed Fraction observed
GDSC IC50 707 139 79262 0.806
CTRP EC50 887 545 387130 0.801
CCLE IC50 504 24 11670 0.965
CCLE EC50 504 24 7626 0.630
0 20 40 60 80 100
(a) GDSC IC50
0 20 40 60 80 100
(b) CTRP EC50
0 2 4 6 8
(c) CCLE IC50
0 2 4 6 8 10
(d) CCLE EC50
Figure 1: Plots of the distribution of values in the drug sensitivity datasets, after capping the extremely
high values in the CTRP EC50 and GDSC IC50 datasets to 100.
4 Additional results
4.1 Convergence speed against time
In the main paper we plotted the convergence speeds of the inference algorithms against
number of iterations taken. Here, we also give the convergence speed against time taken.
The results are given in Figure 2, with the average time per iteration in Table 5 below. We
can see that the ICM and NP methods can be implemented much more efficiently than the
fully Bayesian models, leading to even faster convergence. However, as discussed in the main
paper, as a result of fitting more and faster to the data, the ICM and NP approaches are
also less robust to noise and sparsity. Finally, note the weird fitting behaviour of NP-NMF
on the synthetic data, which occasionally happens.
Table 5: Average time (in seconds) taken per iteration of the four inference approaches for
NMF and NMTF, on the synthetic and four drug sensitivity datasets.
Method Synthetic GDSC IC50 CTRP EC50 CCLE IC50 CCLE EC50
NMF VB 0.015 0.125 0.387 0.067 0.064
NMF Gibbs 0.024 0.251 0.655 0.175 0.143
NMF ICM 0.003 0.047 0.279 0.012 0.012
NMF NP 0.002 0.042 0.268 0.010 0.013
NMTF VB 0.019 0.298 1.703 0.114 0.111
NMTF Gibbs 0.014 0.264 1.557 0.107 0.107
NMTF ICM 0.005 0.173 1.259 0.035 0.034
NMTF NP 0.004 0.124 0.697 0.026 0.030
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4.2 Noise test with ARD
In the main paper we presented the results of the noise test for both NMF and NMTF on
the synthetic data. Here, we demonstrate that the addition of ARD does not have an impact
on the robustness to noise for each of the three probabilistic models (ICM, VB and Gibbs).
The results are given in Figure 3 below, where we see no difference in predictive performance
for any of the models.
4.3 Most common dimensionalities cross-validation
We used nested cross-validation in the main paper to choose the dimensionality K for NMF,
and K,L for NMTF. We give the most common dimensionalities for each of the four drug
sensitivity datasets from this procedure in Table 6 below. This is used for the sparsity
tests. Note that the best dimensionality is roughly the same for NMF and NMTF. VB
and Gibbs have the highest values, because they overfit less when given more factors and
can therefore leverage more of them. The CCLE IC50 dataset has dimensionality 1 for all
methods, indicating that no sensible predictions can be made other than a weighted row and
column average.
Table 6: Most common dimensionalities (K for NMF, K,L for NMTF) of the
inference methods on the four drug sensitivity datasets.
Method GDSC IC50 CTRP EC50 CCLE IC50 CCLE EC50
NMF VB 7 6 5 1
NMF Gibbs 8 7 5 1
NMF ICM 5 4 4 1
NMF NP 6 3 1 1
NMTF VB 5,5 9,9 7,7 1,1
NMTF Gibbs 10,10 8,8 7,7 1,1
NMTF ICM 6,6 6,6 4,4 1,1
NMTF NP 6,6 4,4 1,1 1,1
4.4 Sparsity test on other datasets
We conducted the same sparsity test as in the main paper on the remaining two drug
sensitivity dataset. Results for both NMF and NMTF on all four datasets are given in
Figure 4. As with the other two datasets, on CCLE IC50 and EC50 we see that the VB and
Gibbs versions are much more robust to sparsity than the ICM and NP methods.
4.5 Sparsity test with ARD
We furthermore give the performances in the sparsity test on the four drug sensitivity
datasets of the methods with ARD. We see in Figure 5 that adding ARD makes no dif-
ference to the robustness to sparsity for the fully Bayesian models (VB and Gibbs), but for
the ICM version it can greatly increase its robustness: notice how ICM with ARD (black
line) often performs better than ICM (green line).
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4.6 Model selection on other datasets
Finally, we conducted the model selection experiment on the remaining three drug sensitivity
datasets. Results on all four are given in Figure 6 for NMF, and Figure 7 for NMTF. We can
see that the ARD also works very well on the other three datasets, particularly for the ICM
approach. On the CCLE IC50 and EC50 datasets the Gibbs and VB models do not need
the ARD to keep a flat line, demonstrating that the fully Bayesian approaches are naturally
robust to overfitting already (although it can help—as can be seen on the CTRP and GDSC
datasets).
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(a) NMF, synthetic (b) NMF, GDSC (c) NMF, CTRP (d) NMF, CCLE IC50 (e) NMF, CCLE EC50
(f) NMTF, synthetic (g) NMTF, GDSC (h) NMTF, CTRP (i) NMTF, CCLE
IC50
(j) NMTF, CCLE
EC50
Figure 2: Convergence of algorithms on the synthetic and drug sensitivity datasets, measuring the training
data fit (mean square error) across iterations and time taken, for each of the inference approaches for NMF
(top two rows) and NMTF (bottom two rows).
(a) NMF (b) NMTF
Figure 3: Noise test performances, measured by average predictive performance on test set (mean square
error) for different noise-to-signal ratios.
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(a) GDSC, NMF (b) CTRP, NMF (c) CCLE IC50, NMF (d) CCLE EC50, NMF
(e) GDSC, NMTF (f) CTRP, NMTF (g) CCLE IC50, NMF (h) CCLE EC50, NMF
Figure 4: Sparsity test performances on all four drug sensitivity datasets, measured by average predictive
performance on test set (mean square error) for different sparsity levels.
(a) GDSC, NMF (b) CTRP, NMF (c) CCLE IC50, NMF (d) CCLE EC50, NMF
(e) GDSC, NMTF (f) CTRP, NMTF (g) CCLE IC50, NMTF (h) CCLE EC50, NMTF
Figure 5: Sparsity test performances for all methods (with and without ARD) on the four drug sensitivity
datasets, measured by average predictive performance on test set (mean square error) for different sparsity
levels. The top row gives the performances for NMF, and the bottom for NMTF.
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(a) GDSC, NMF (b) CTRP, NMF (c) CCLE IC50, NMF (d) CCLE EC50, NMF
Figure 6: 10-fold cross-validation performances of the Bayesian NMF models on the drug sensitivity datasets,
where we vary the dimensionality K. The top row gives the performances for NMF VB, the middle row for
NMF Gibbs, and the bottom row for NMF ICM. Performances for models without ARD are given by dotted
lines and crosses (x), with ARD by circles (o).
(a) GDSC, NMTF (b) CTRP, NMTF (c) CCLE IC50, NMTF (d) CCLE EC50, NMTF
Figure 7: 10-fold cross-validation performances of the Bayesian NMTF models on the drug sensitivity
datasets, where we vary the dimensionality K and L (L = K). The top row gives the performances for
NMTF VB, the middle row for NMTF Gibbs, and the bottom row for NMTF ICM. Performances for models
without ARD are given by dotted lines and crosses (x), with ARD by circles (o).
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